Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment | |
Shi, Wenyin; Blomain, Erik S.; Siglin, Joshua; Palmer, Joshua D.; Dan, Tu; Wang, Yang; Werner-Wasik, Maria; Glass, Jon; Kim, Lyndon; Bar Ad, Voichita | |
刊名 | JOURNAL OF NEURO-ONCOLOGY
![]() |
2018 | |
卷号 | 137期号:1 |
关键词 | High grade glioma Re-irradiation Bevacizumab Stereotactic radiation Glioblastoma |
ISSN号 | 0167-594X |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3602967 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Shi, Wenyin,Blomain, Erik S.,Siglin, Joshua,et al. Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment[J]. JOURNAL OF NEURO-ONCOLOGY,2018,137(1). |
APA | Shi, Wenyin.,Blomain, Erik S..,Siglin, Joshua.,Palmer, Joshua D..,Dan, Tu.,...&Andrews, David W..(2018).Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.JOURNAL OF NEURO-ONCOLOGY,137(1). |
MLA | Shi, Wenyin,et al."Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment".JOURNAL OF NEURO-ONCOLOGY 137.1(2018). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论